Annexon presents archer trial results at asrs 2023 highlighting potential of anx007 as a differentiated treatment for geographic atrophy

Additional analyses support consistent protection from vision loss annexon to engage with regulatory agencies to determine optimal path forward for anx007 company to hold investor conference call on monday, july 31, 2023, at 1:30 p.m. pt / 4:30 p.m.

ANNX Ratings Summary

ANNX Quant Ranking